Study Summary
This trial will test whether a parent and adolescent intervention can help reduce the risk of STIs, HIV, and unintended pregnancies among young people in Botswana.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
11 Primary · 0 Secondary · Reporting Duration: one year
Trial Safety
Safety Progress
Trial Design
3 Treatment Groups
FM2 first, LAST delayed
1 of 3
FM2 and LAST simultaneous
1 of 3
Comparison arm
1 of 3
Active Control
1000 Total Participants · 3 Treatment Groups
Primary Treatment: FM2 first, LAST delayed · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 13 - 80 · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is there a call for participants in this clinical investigation?
"Clinicaltrials.gov confirms that this medical study is recruiting patients, having been first posted on April 22nd 2019 and recently updated September 18th 2020." - Anonymous Online Contributor
Does this study have an age restriction, and if so is it accommodating individuals over eighty-five?
"This trial seeks to include participants aged 13-80. There are additional specialised trials available for those under 18 and above 65 years old, respectively." - Anonymous Online Contributor
What is the current enrollment rate for this research project?
"Affirmative. The information located on clinicaltrials.gov indicates that the trial is actively recruiting patients, having been first posted on April 22nd 2019 and last updated on September 18th 2020. This medical study requires 1000 participants from one site." - Anonymous Online Contributor
What is the accepted demographic of participants in this experiment?
"The research team is actively searching for 1000 patients aged 13 to 80 with reproductive health issues, who are located in Gaborone Botswana and have a parent or guardian." - Anonymous Online Contributor